Treatment of vns-induced laryngospasm with botulinum toxin.
Kumar
S
S
Department of Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA.
Sharafkhaneh
A
A
Edmonds
J
J
Schultz
R
R
Hopkins
B
B
D000293:Adolescent; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D004827:Epilepsy / Q000628:therapy; D006801:Humans; D007826:Laryngismus / Q000188:drug therapy* / Q000209:etiology*; D008297:Male; D017286:Polysomnography / Q000379:methods; D055536:Vagus Nerve Stimulation / Q000009:adverse effects*
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins